Literature DB >> 20849428

The risk of meningococcal disease in travelers and current recommendations for prevention.

Robert Steffen1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849428     DOI: 10.1111/j.1708-8305.2010.00449.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  5 in total

Review 1.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

Review 2.  Travel vaccines: Update for Canadian pharmacists.

Authors:  Christina Bascom
Journal:  Can Pharm J (Ott)       Date:  2019-10-11

3.  Awareness of meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa.

Authors:  Anna L Goodman; Cristina Masuet-Aumatell; Jay Halbert; Jane N Zuckerman
Journal:  Am J Trop Med Hyg       Date:  2014-06-02       Impact factor: 2.345

4.  Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.

Authors:  Charissa Fay Corazon Borja-Tabora; Cecilia Montalban; Ziad A Memish; Dominique Boutriau; Devayani Kolhe; Jacqueline M Miller; Marie Van der Wielen
Journal:  BMC Infect Dis       Date:  2015-10-06       Impact factor: 3.090

5.  Vaccination and Malaria Prevention among International Travelers Departing from Athens International Airport to African Destinations.

Authors:  Androula Pavli; Athina Spilioti; Paraskevi Smeti; Stavros Patrinos; Helena C Maltezou
Journal:  J Trop Med       Date:  2014-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.